GR3005034T3 - - Google Patents

Info

Publication number
GR3005034T3
GR3005034T3 GR920401363T GR920401363T GR3005034T3 GR 3005034 T3 GR3005034 T3 GR 3005034T3 GR 920401363 T GR920401363 T GR 920401363T GR 920401363 T GR920401363 T GR 920401363T GR 3005034 T3 GR3005034 T3 GR 3005034T3
Authority
GR
Greece
Prior art keywords
alkyl
cr3r4
cycloalkylidene
phenyl
salts
Prior art date
Application number
GR920401363T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005034T3 publication Critical patent/GR3005034T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR920401363T 1986-12-23 1992-06-25 GR3005034T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8618082A FR2608603A1 (fr) 1986-12-23 1986-12-23 Nouvelles piperidines ou azepines substituees, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
GR3005034T3 true GR3005034T3 (enExample) 1993-05-24

Family

ID=9342238

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401363T GR3005034T3 (enExample) 1986-12-23 1992-06-25

Country Status (16)

Country Link
US (1) US4820702A (enExample)
EP (1) EP0275760B1 (enExample)
JP (1) JPS63190875A (enExample)
KR (1) KR950009361B1 (enExample)
AT (1) ATE74351T1 (enExample)
AU (1) AU603852B2 (enExample)
CA (1) CA1314882C (enExample)
DE (1) DE3777999D1 (enExample)
DK (1) DK675287A (enExample)
ES (1) ES2036594T3 (enExample)
FI (1) FI84265C (enExample)
FR (1) FR2608603A1 (enExample)
GR (1) GR3005034T3 (enExample)
NZ (1) NZ222973A (enExample)
PT (1) PT86443B (enExample)
ZA (1) ZA879429B (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081309A (en) * 1963-03-12 Table vi
US2976146A (en) * 1958-11-28 1961-03-21 Eastman Kodak Co Novel cyan-forming couplers
GB1051322A (enExample) * 1967-08-09
CH492710A (de) * 1968-01-11 1970-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Piperidinderivaten

Also Published As

Publication number Publication date
FI84265B (fi) 1991-07-31
PT86443B (pt) 1990-11-20
AU603852B2 (en) 1990-11-29
FI875654A0 (fi) 1987-12-22
DK675287D0 (da) 1987-12-21
EP0275760B1 (fr) 1992-04-01
DE3777999D1 (de) 1992-05-07
AU8291287A (en) 1988-06-23
ATE74351T1 (de) 1992-04-15
ES2036594T3 (es) 1993-06-01
PT86443A (en) 1988-01-01
FI875654L (fi) 1988-06-24
ZA879429B (en) 1988-06-10
KR880007464A (ko) 1988-08-27
KR950009361B1 (ko) 1995-08-21
DK675287A (da) 1988-06-24
NZ222973A (en) 1989-12-21
US4820702A (en) 1989-04-11
CA1314882C (en) 1993-03-23
EP0275760A1 (fr) 1988-07-27
FR2608603A1 (fr) 1988-06-24
JPS63190875A (ja) 1988-08-08
FI84265C (fi) 1991-11-11

Similar Documents

Publication Publication Date Title
GEP20001917B (en) Macrolidal Antibiotic.
ES8802521A1 (es) Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas
NZ215008A (en) Heterocyclic compounds and herbicidal compositions
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
ATE12224T1 (de) Verbindungen mit antifibrinolytischer wirksamkeit.
YU89691A (sh) Postupak za dobijanje stereoselektivnih derivata fenilizoserina
PH25725A (en) Fungicides
MY102277A (en) Quinoline compounds
ES8607300A1 (es) Acidos 1,7-diamino-1,4-dihidro-4-oxo-3-(aza) quinolincarbo- xilicos
GR3002051T3 (en) 3-oxadiazolyl and 3-carboxylic-acid beta-carboline derivatives, their preparation and their use as medicaments
FR2540870B1 (enExample)
ES8602773A1 (es) Procedimiento para la fabricacion de derivados del dioxolano de tipo azolico
MY100938A (en) Arylkylimidazole derivatives.
PT86443A (en) New substituted 3-piperidinamines or 3-azepinamines the preparation thereof and their applications in therapy
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
ES8602352A1 (es) Procedimiento para preparar derivados de 2-alcoxiaminosulfo-nilbencenosulfonilurea
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
JO1274B1 (en) Pyridine derivatives
AU553351B2 (en) Organophosphate derivatives
EP0225634A3 (en) Antibacterial compounds, their production and use
ES8404335A1 (es) Procedimiento para la obtencion de alquilen(cicloalquilen)-bis-heterociclil-biguanidas.
ATE69819T1 (de) 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles mittel.
ES8301233A1 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
MY101831A (en) Fungicides.
IT1214534B (it) 4-cloro-arilossi-acetil-e 4-cloro-arilossi-propionil-malonati aventi proprieta' erbicide.